PubMed:33012699
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 115-148 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 162-170 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T3 | 234-281 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 234-267 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 283-291 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 742-750 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 906-914 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 15-16 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 66-67 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T3 | 76-81 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T4 | 657-665 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T5 | 682-685 | http://purl.obolibrary.org/obo/CLO_0037067 | denotes | VAL |
T6 | 703-711 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T7 | 762-767 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T8 | 834-837 | http://purl.obolibrary.org/obo/CLO_0037067 | denotes | VAL |
T9 | 838-841 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T10 | 874-875 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 0-11 | Chemical | denotes | Valinomycin | http://purl.obolibrary.org/obo/CHEBI_28545 |
T2 | 27-42 | Chemical | denotes | antiviral agent | http://purl.obolibrary.org/obo/CHEBI_22587 |
T3 | 533-537 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T4 | 562-567 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T5 | 647-656 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T6 | 669-680 | Chemical | denotes | valinomycin | http://purl.obolibrary.org/obo/CHEBI_28545 |
T7 | 682-685 | Chemical | denotes | VAL | http://purl.obolibrary.org/obo/CHEBI_28545 |
T8 | 834-837 | Chemical | denotes | VAL | http://purl.obolibrary.org/obo/CHEBI_28545 |
T9 | 882-897 | Chemical | denotes | antiviral agent | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 0-11 | Chemical | denotes | Valinomycin | MESH:D014634 |
3 | 51-64 | Species | denotes | coronaviruses | Tax:11118 |
22 | 76-81 | Species | denotes | Human | Tax:9606 |
23 | 82-95 | Species | denotes | coronaviruses | Tax:11118 |
24 | 115-160 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
25 | 162-170 | Species | denotes | SARS-CoV | Tax:694009 |
26 | 173-228 | Species | denotes | Middle East respiratory syndrome coronavirus (MERS-CoV) | Tax:1335626 |
27 | 234-281 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
28 | 283-293 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
29 | 361-370 | Disease | denotes | mortality | MESH:D003643 |
30 | 457-470 | Species | denotes | coronaviruses | Tax:11118 |
31 | 669-680 | Chemical | denotes | valinomycin | MESH:D014634 |
32 | 682-685 | Chemical | denotes | VAL | MESH:D014634 |
33 | 720-733 | Species | denotes | coronaviruses | Tax:11118 |
34 | 742-750 | Species | denotes | SARS-CoV | Tax:694009 |
35 | 752-760 | Species | denotes | MERS-CoV | Tax:1335626 |
36 | 762-784 | Species | denotes | human coronavirus OC43 | Tax:31631 |
37 | 786-795 | Species | denotes | HCoV-OC43 | Tax:31631 |
38 | 834-837 | Chemical | denotes | VAL | MESH:D014634 |
39 | 906-916 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-65 | Sentence | denotes | Valinomycin as a potential antiviral agent against coronaviruses: |
T2 | 66-75 | Sentence | denotes | A review. |
T3 | 76-371 | Sentence | denotes | Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been resulting in global epidemics with heavy morbidity and mortality. |
T4 | 372-471 | Sentence | denotes | Unfortunately, there are currently no specific medicines that can better treat these coronaviruses. |
T5 | 472-611 | Sentence | denotes | Drug repurposing is an effective and economical strategy for drug discovery from existing drugs, natural products, and synthetic compounds. |
T6 | 612-917 | Sentence | denotes | In this review, the broad-spectrum antiviral activity of valinomycin (VAL), especially its activity against coronaviruses such as SARS-CoV, MERS-CoV, human coronavirus OC43 (HCoV-OC43), were summarized, it highlights that VAL has tremendous potential for use as a novel antiviral agent against SARS-CoV-2. |